treprostinil sodium
RIV-PH-413
Approved small_molecule terminated
Quick answer
treprostinil sodium for Hypertension, Pulmonary is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 2 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Hypertension, Pulmonary
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated